You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort

Article metrics

Article menu

Download PDFPDF

Systemic sclerosis
Original research
Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort

 

Online download statistics by month:

Online download statistics by month: November 2022 to March 2024

AbstractFullPdf
Nov 2022713717377
Dec 2022377376116
Jan 202320520162
Feb 202319018972
Mar 20234258642590183
Apr 2023232502325096
May 20231064106555
Jun 20231374137651
Jul 20231310130164
Aug 20231147114252
Sep 20231052104950
Oct 202374173639
Nov 202336735929
Dec 202326926640
Jan 202420920250
Feb 202417417551
Mar 202418618455
Total75214751781442